Erste Asset Management Gmb H Twist Bioscience Corp Transaction History

Erste Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 26, 2024	SELL	$18.62 - $26.57 $355,642 - $507,487	-19,100 Closed	0 $0
Q1 2023 Nov 26, 2024	SELL	$14.6 - $30.9 $278,860 - $590,190	-19,100 Closed	0 $0
Q3 2022 Nov 26, 2024	BUY	$33.44 - $56.56 $638,704 - $1.08 Million	19,100 New	19,100 $683 Million
Q2 2022 Nov 26, 2024	BUY	$26.2 - $54.0 $500,420 - $1.03 Million	19,100 New	19,100 $664 Million
Q1 2022 Nov 22, 2024	BUY	$38.58 - $83.27 $235,338 - $507,947	6,100 Added 122.0%	11,100 $558 Million
Q4 2021 Nov 22, 2024	BUY	$75.47 - $135.88 $377,350 - $679,400	5,000 New	5,000 $377 Million
Q1 2021 Nov 22, 2024	SELL	$105.48 - $207.97 $727,812 - $1.43 Million	-6,900 Reduced 57.98%	5,000 $549 Million
Q4 2020 Nov 22, 2024	BUY	$76.64 - $167.89 $912,016 - $2 Million	11,900 New	11,900 $1.65 Billion

257

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.77B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.